People · Operator
Named in public records as an officer, director or promoter · active 2021–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Inmedix, Inc. | — | Biotechnology | Pre-Seed | $1.8M | $344K | 2021 |
Andrew J Holman at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew J Holman on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bernie Tobin | 1 | 1 |
| Andrew Holman, M.D. | 1 | 1 |
| Steven Daly, M.S., M.B.A. | 1 | 1 |
| Leroy Hood, M.D., Ph.D. | 1 | 1 |
| Kevin Tracey, M.D. | 1 | 1 |
| Ryan Sullivan, Ph.D. | 1 | 1 |
| Steven J. Daly | 1 | 1 |
| Bernie J. Tobin | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.